Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Resuscitation. 2021 May;162:334-342. doi: 10.1016/j.resuscitation.2021.01.011. Epub 2021 Jan 21.
We aimed to evaluate neurological profiles of patients with in-hospital cardiac arrest (IHCA) from early time points to long-term follow-up periods.
For this prospective cohort study, we established a neurological rapid response team, and serially evaluated the neurological status of patients with IHCA from the initial resuscitation to 12 months after the onset of IHCA. The primary outcome was good neurological status defined as a Clinical Performance Category score of 1-2 at 12 months after IHCA. The secondary outcomes included the awakening and neurological recovery during the first week, the survival and neurological status at hospital discharge, and the survival at 12 months.
A total of 291 adult patients with IHCA were included. On the first day and during the first week after IHCA, the awakening was achieved in 61 (21.0 %) and 119 patients (40.9 %), respectively; and neurological recovery in 12 (4.1 %) and 46 patients (15.8 %), respectively. Epileptic seizures developed in 9.7 % following restoration of spontaneous circulation. At hospital discharge, 106 patients (36.4 %) had survived; among them, 63.2 % showed good neurological status. At 12 months, 63 (21.6 %) patients survived; among them, 81.7 % showed good neurological status (17.0 % among all patients with IHCA). Of patients without awakening during the first 3 and 7 days, 2.7 % and 1.2 % showed good neurological status at 12 months, respectively.
Among patients with IHCA, awakening and neurological recovery were remarkable throughout the first week. Survival and good neurological status were substantial at 12 months after IHCA.
我们旨在评估院内心搏骤停(IHCA)患者从早期时间点到长期随访期间的神经学特征。
在这项前瞻性队列研究中,我们建立了一个神经学快速反应团队,并从初始复苏开始,连续评估 IHCA 后 12 个月内 IHCA 患者的神经状态。主要结局是良好的神经状态,定义为 IHCA 后 12 个月时临床表现类别评分 1-2 分。次要结局包括第 1 周期间的觉醒和神经恢复,出院时的生存和神经状态,以及 12 个月时的生存。
共纳入 291 例成人 IHCA 患者。在 IHCA 后第 1 天和第 1 周,分别有 61 例(21.0%)和 119 例(40.9%)患者觉醒;分别有 12 例(4.1%)和 46 例(15.8%)患者出现神经恢复。自主循环恢复后,9.7%的患者发生癫痫发作。出院时,106 例(36.4%)患者存活;其中,63.2%患者神经状态良好。在 12 个月时,63 例(21.6%)患者存活;其中,81.7%患者神经状态良好(所有 IHCA 患者中占 17.0%)。在第 3 天和第 7 天无觉醒的患者中,分别有 2.7%和 1.2%在 12 个月时神经状态良好。
在 IHCA 患者中,第 1 周期间觉醒和神经恢复显著。IHCA 后 12 个月时的生存和良好的神经状态显著。